Invesco Mutual Fund has increased its holding in Sai Life Sciences to 7.2777% as of October 13, 2025. This represents a change of 2.0685% from the last disclosure. The acquisition was made through open market purchases, signaling continued investor confidence in Sai Life Sciences.
Invesco Mutual Fund’s Increased Investment
Invesco Mutual Fund, through its various schemes, has increased its investment in Sai Life Sciences. As of October 13, 2025, the aggregate holding of certain schemes of Invesco Mutual Fund in Sai Life Sciences reached 7.2777% of the company’s paid-up share capital.
Details of the Acquisition
Prior to the recent acquisition, Invesco Mutual Fund held 1,51,26,828 shares, representing 7.2091% of the total share capital. The acquisition involved purchasing an additional 1,43,820 shares, which accounts for 0.0685% of the total share capital.
Post-Acquisition Holding
Following the acquisition on October 13, 2025, Invesco Mutual Fund now holds a total of 1,52,70,648 shares in Sai Life Sciences, representing 7.2777% of the total share capital. This acquisition was executed through open market purchases.
Source: BSE
